Endoscopic retrograde cholangiopancreatography (ERCP) is a critical, life-saving and highly technical endoscopic procedure. The vast majority of people will never have an ERCP. The procedure allows GIs to diagnose and treat problems in the bile duct and pancreatic ducts such as stones, narrowing (called strictures) and even complete blockages of the ducts.
Capnography for Moderate Sedation
Feb. 14, 2012
Medical Position Statement on Endoscopic Sedation
Aug. 1, 2007
Digestive Disease Week® (DDW)
May 21, 2016
ERCP and EUS
Aug. 16, 2015
GI Innovation: A Year in Review
March 8, 2016
A growing number of antibiotic-resistant infections have been reported following use of a specialized medical device called a duodenoscope, which is used in the advanced procedure endoscopic retrograde cholangiopancreatography, or ERCP. The AGA Center for GI Innovation and Technology convened a meeting, “Getting to Zero,” with experts in gastroenterology, epidemiology and infectious disease; the endoscope manufacturers Fuji and Pentax; and representatives from the U.S. FDA, CDC and ECRI Institute to discuss how to prevent these infections.
FDA Safety Communication: Supplemental Measures to Enhance Duodenoscope Reprocessing
Dr. Michael Kochman, chair of the AGA Center for GI Innovation and Technology, provides an important update on this issue and discusses AGA's plans to develop short- and long-term solutions to address the proper cleansing of duodenoscopes.
Manage Your Practice
Manage your practice with useful resources and practice improvement tools including CPT, HCPCS, ICD-9 and ICD-10 codes that are commonly used for GI procedures.
Educate Your Patients
AGA provides patient guides, books and other resources to help your patients understand the procedures they are about to undergo.